An under-the-radar immune cell shows potential in fight against cancer
ILC2 cells were discovered as a major player in asthma. Wilf Jefferies found they may also stop cancer from metastasizing.
Vancouver part of multi-million-dollar Healthy Cities project
Vancouver and four other cities will be examined for ways to reduce health inequities through better development and service delivery.
Do men’s toenails contain clues about prostate cancer prevention?
Researchers will analyze concentrations of toxic metals and look for correlations with the histories of prostate cancer patients.
Midwifery linked to better birth outcomes in state-by-state “report card”
States with higher midwifery integration, like Washington and Oregon, generally had better results,
Study finds that Canadians giving up food, heat to pay for prescription drugs
8.2 per cent of those who received a prescription in 2016 did not take medication as prescribed because of the cost,
An unexpected target — and weapon — for one of the deadliest cancers
A new drug, fostamatinib, reduced the growth rate of esophageal adenocarcinoma in mice by at least 70 per cent.
Use of fentanyl signals limits of substitution therapy for many Downtown Eastside residents
The study of people living in marginal housing also showed how quickly fentanyl infiltrated the community in 2017.
Indigenous people face higher risk of transportation injuries in B.C.
Overall hospitalization rates for transport injuries in B.C. declined by more than two-thirds between 1991 and 2010.
UBC Medicine receives 40% of national genomics funding
The 10 projects, totaling $101 million, include an effort to reduce the risk of kidney transplant rejection.
By jamming a lock, UBC scientists stop cancer cell growth
A team led by Christopher Ong in Urologic Sciences developed a protein-based drug that stops unrestricted cell proliferation. Next step: A clinical trial.